Part Details | VINCRISTINE SULFATE INJECTION
6505-01-151-2341
Alternate Parts: ONCOVIN, NDC61703030916, NDC61703-0309-16, NDC00469352010, NDC00469-3520-10, 35202, NDC00703441211, NDC00703-4412-11, 6505-01-151-2341, 01-151-2341, 6505011512341, 011512341
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | APR 14, 1983 | 01-151-2341 | 37094 ( VINCRISTINE SULFATE INJECTION ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-151-2341
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| ONCOVIN | 75602 | ELI LILLY AND COMPANY |
| NDC61703-0309-16 | 05BB8 | FAULDING PHARMACEUTICALS |
| NDC00469-3520-10 | 60567 | LYPHOMED INCDIV OF FUJISAWA USA INC |
| 35202 | 60567 | LYPHOMED INCDIV OF FUJISAWA USA INC |
| NDC00703-4412-11 | 0Y512 | SICOR PHARMACEUTICALS SALES INC |
Technical Data | NSN 6505-01-151-2341
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | BY1.000 MILLIGRAMS VINCRISTINE SULFATE |
| PRIMARY CONTAINER TYPE | VIAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 2.000 MILLILITERS |
| PROTECTIVE STORAGE FEATURE | ANTINEOPLASTIC DRUG |
| THERAPEUTIC EQUIVALENT | ANY A RATED DRUG |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | VINCRISTINE SULFATE INJECTION USP 1MG/ML 2ML VIAL |